We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

Donald Trump and RFK have caused mayhem in the US medical research market. It's clearing a path for Aussie drug trial contractor IDT.

GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

Mid-cap stocks play an important role in a balanced portfolio, offering a middle ground between the stability of large caps and the growth potential of small caps. Mid-cap businesses are generally ...

Both FIIs and DIIs showed a marked preference for large-cap stocks, underscoring their appetite ... FIIs raised their stake from 17.3% to 17.5%, while DIIs increased theirs from 5.8% to 6.3%.

The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...

Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...